Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
Titel:
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
Auteur:
Buse, John B Rosenstock, Julio Sesti, Giorgio Schmidt, Wolfgang E Montanya, Eduard Brett, Jason H Zychma, Marcin Blonde, Lawrence